MR angiography of the pedal arteries with gadobenate dimeglumine, a contrast agent with increased relaxivity, and comparison with selective intraarterial DSA

Journal of Magnetic Resonance Imaging

Volumn 27, Issue 1, 2008, Pages 78-85

  Kreitner, Karl Friedrich ^a   Kunz, R Peter ^a   Herber, Sascha ^a   Martenstein, Sonja ^a   Dorweiler, Bernhard ^a   Dueber, Christoph ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Contrast enhanced MR angiography; Gadobenate dimeglumine; Image quality; Pedal vasculature; Selective intraarterial digital subtraction angiography; Vessel patency

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; IOPROMIDE;

ADULT; AGED; ARTICLE; ARTIFACT; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METATARSAL BONE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY, DIGITAL SUBTRACTION; ARTERIAL OCCLUSIVE DISEASES; CONTRAST MEDIA; FEMALE; FOOT; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; VASCULAR PATENCY;

EID: 37849004535     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21226     Document Type: Article

References (36)

1. Armstrong DG, Lavery LA. Diabetic foot ulcers: prevention, diagnosis and classification. Am Fam Physician 1998;15:1325-1332.
2. Dyet JF, Nicholson AA, Ettles DFE. Vascular imaging and intervention in peripheral arteries in the diabetic patient. Diabetes Metab Res Rev 2000;16(Suppl 1):S16-S22.
3. Chomel S, Douek P, Moulin P, Vaudoux M, Marchand B. Contrast-enhanced MR angiography of the foot: anatomy and clinical application in patients with diabetes. AJR Am J Roentgenol 2004;182:1435-1442.
4. Kreitner K-F, Kalden P, Neufang A, et al. Diabetes and peripheral arterial occlusive disease: prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography. AJR Am J Roentgenol 2000;174:171-179.
5. Lapeyre M, Kobeiter H, Desgranges P, Rahmouni A, Becquemin J-P, Luciani A. Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography. AJR Am J Roentgenol 2005;185:1641-1650.
6. Dorweiler B, Neufang A, Kreitner K-F, Schmiedt W, Oelert H. Magnetic resonance angiography unmasks reliable target vessels for pedal bypass grafting in patients with diabetes mellitus. J Vasc Surg 2002;35:766-772.
7. Young N, Chi KK, Ajaka J, MyKay L, O'Neill D, Wong KP. Complications with outpatient angiography and interventional procedures. Cardiovasc Intervent Radiol 2002;25:123-126.
8. Tsuchiya M, Suzuki E, Egawa K, et al. Abnormal peripheral circulation in type 2 diabetic patients with normal ankle-brachial index associates with coronary atherosclerosis, large artery stiffness, and peripheral vascular resistance. Diabetes Res Clin Pract 2005;70:253-262.
9. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243:148-157.
10. Hofmann WJ, Forstner R, Kofler B, Binder K, Ugurluoglu A, Magometschnigg H. Pedal artery imaging - a comparison of selective digital subtraction angiography, contrast enhanced magnetic resonance angiography and duplex ultrasound. Eur J Endovasc Surg 2002;24:287-292.
11. Cronberg CN, Sjöberg S, Albrechtsson U, et al. Peripheral arterial disease. Contrast-enhanced 3D MR angiography of the lower leg and foot compared with conventional angiography. Acta Radiol 2003;44:59-66.
12. Goyen M, Debatin JF. Gadobenate dimeglumine (MultiHance®) for magnetic resonance angiography: review of the literature. Eur Radiol 2003;13(Suppl 3):N19-N27.
13. Pintaske J, Martirosian P, Graf H, et al. Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 2005;40:715-724.
14. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005;40:715-724.
15. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997;32:780-796.
16. Giesel FL, von Tengg-Kobligk H, Wilkinson ID, et al. Influence of human serum albumin on longitudinal and transverse relaxation rates (R1 and R2) of magnetic resonance contrast agents. Invest Radiol 2006;41:222-228.
17. Knopp MV, Schoenberg SO, Rehm C, et al. Assessment of gadobenate dimeglumine for magnetic resonance angiography. Invest Radiol 2002;37:706-715.
18. Knopp MV, Giesel FL, Tengg-Kobligk H von, et al. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging 2003;17:694-702.
19. Wikström J, Wasser NM, Pattynama PMT, et al. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the pelvic arteries. Invest Radiol 2003;38:504-515.
20. Kroencke TJ, Wasser MN, Pattynama PMT, et al. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the abdominal aorta and renal arteries. AJR Am J Roentgenol 2002;179:1573-1582.
21. Wyttenbach R, Gianella S, Alerci M, Braghetti A, Cozzi, L, Gfallino A. Prospective blinded evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography. Radiology 2003;227:261-269.
22. Völk M, Strotzer M, Lenhart M, et al. Renal time-resolved MR angiography: quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses. Radiology 2001;220:484-488.
23. Sacks D, Marinelli DL, Martin LG, Spies JB, and members of the Technology Assessment Committee. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol 1997;8:137-149.
24. Gates J; Hartnell GG. Optimized diagnostic angiography in high-risk patients with severe peripheral vascular disease. Radiographics 2000;20:1221-133.
25. Maki JH. Pedal MR angiography. In: Schneider G, editors: Magnetic resonance angiography - techniques, indications and practical applications. Milan-Berlin-Heidelberg-New York, Springer; 2004. p 285-300.
26. Prokop M, Schneider G, Vanzulli A, et al. Contrast-enhanced MR angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2005;234:399-408.
27. Laurent, S, Elst LV, Muller RN. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging 2006;1:128-137.
28. Thumher S, Miller S, Schneider G, et al. Diagnostic performance of Gadobenate dimeglumine-enhanced MRI angiography of the iliofemoral and calf arteries: a large-scale multicenter trial. AJR Am J Roentgenol 2007;189:1223-1237.
29. Goyen M, Herborn CU, Kröger K, Ruehm SG, Debatin JF. Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease. Eur Radiol 2006;16:685-691.
30. Zhang HL, Maki JH, Prince MR. 3D contrast-enhanced MR angiography. J Magn Reson Imaging 2007;25:13-25.
31. Vogt FM, Ajaj W, Hunold P, et al. Venous compression at high-spatial-resolution three-dimensional MR angiography of peripheral arteries. Radiology 2004;233:913-920.
32. von Kalle T, Gerlach A, Hatopp A, Klinger S, Prodehl P, Arlart IP. Kontrastverstärkte MR-Angiographie (CEMRA) bei peripherer AVK (pAVK): konventionelle Tischverschiebetechnik versus Hybrid-Technik. [Contrast-enhanced MR angiography (CEMRA) in peripheral arterial occlusive disease (PAOD): conventional moving table technique versus hybrid technique]. Rofo 2004;176:62-69. [German]
33. Tongdee R, Narra VR, McNeal G, et al. Hybrid peripheral 3D contrast-enhanced MR angiography of calf and foot vasculature. AJR Am J Roentgenol 2005;186:1746-1753.
34. Schmitt R, Coblenz G, Cherevatyy O, et al. Comprehensive MR angiography of the lower limbs: a hybrid dual-bols approach including the pedal arteries. Eur Radiol 2005;15:2513-2524.
35. Meissner OA, Rieger J, Weber C, et al. Critical limb ischemia: hybrid MR angiography compared with DSA. Radiology 2005;235:308-318.
36. Andreisek G, Pfammatter T, Goepfert K, et al. Peripheral arteries in diabetic patients: standard bolus-chase and time-resolved MR angiography. Radiology 2007;242:610-620.